RGB-286638
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RGB-286638, covering 2012-08-02 to 2012-08-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies [Phase 1]